This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, E.
Right arrow Articles by Lobigs, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, E.
Right arrow Articles by Lobigs, M.

 Previous Article  |  Next Article 

Journal of Virology, May 2002, p. 4901-4911, Vol. 76, No. 10
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.10.4901-4911.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mechanism of Virulence Attenuation of Glycosaminoglycan-Binding Variants of Japanese Encephalitis Virus and Murray Valley Encephalitis Virus

Eva Lee* and Mario Lobigs

Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia

Received 14 December 2001/ Accepted 8 February 2002

The in vivo mechanism for virulence attenuation of laboratory-derived variants of two flaviviruses in the Japanese encephalitis virus (JEV) serocomplex is described. Host cell adaptation of JEV and Murray Valley encephalitis virus (MVE) by serial passage in adenocarcinoma cells selected for variants characterized by (i) a small plaque phenotype, (ii) increased affinity to heparin-Sepharose, (iii) enhanced susceptibility to inhibition of infectivity by heparin, and (iv) loss of neuroinvasiveness in a mouse model for flaviviral encephalitis. We previously suggested that virulence attenuation of the host cell-adapted variants of MVE is a consequence of their increased dependence on cell surface glycosaminoglycans (GAGs) for attachment and entry (E. Lee and M. Lobigs, J. Virol. 74:8867-8875, 2000). In support of this proposition, we find that GAG-binding variants of JEV and MVE were rapidly removed from the bloodstream and failed to spread from extraneural sites of replication into the brain. Thus, the enhanced affinity of the attenuated variants for GAGs ubiquitously present on cells and extracellular matrices most likely prevented viremia of sufficient magnitude and/or duration required for virus entry into the brain parenchyma. This mechanism may also account, in part, for the attenuation of the JEV SA14-14-2 vaccine, given the sensitivity of the virus to heparin inhibition. A pronounced loss of the capacity of the GAG-binding variants to produce disease was also noted in mice defective in the alpha/beta interferon response, a mouse strain shown here to be highly susceptible to infection with JEV serocomplex flaviviruses. Despite the close genetic relatedness of JEV and MVE, the variants selected for the two viruses were altered at different residues in the envelope (E) protein, viz., Glu306 and Asp390 for JEV and MVE, respectively. In both cases the substitutions gave the protein an increased net positive charge. The close spatial proximity of amino acids 306 and 390 in the predicted E protein structure strongly suggests that the two residues define a receptor-binding domain involved in virus attachment to sulfated proteoglycans.

* Corresponding author. Mailing address: Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, P.O. Box 334, Canberra, ACT 2601, Australia. Phone: 61-2-61253526. Fax: 61-2-61252595. E-mail: Eva.Lee{at}anu.edu.au.

Journal of Virology, May 2002, p. 4901-4911, Vol. 76, No. 10
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.10.4901-4911.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • O'Donnell, C. D., Shukla, D. (2009). A Novel Function of Heparan Sulfate in the Regulation of Cell-Cell Fusion. J. Biol. Chem. 284: 29654-29665 [Abstract] [Full Text]  
  • Anez, G., Men, R., Eckels, K. H., Lai, C.-J. (2009). Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques. J. Virol. 83: 10384-10394 [Abstract] [Full Text]  
  • Lobigs, M., Larena, M., Alsharifi, M., Lee, E., Pavy, M. (2009). Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus. J. Virol. 83: 2436-2445 [Abstract] [Full Text]  
  • Nickells, J., Cannella, M., Droll, D. A., Liang, Y., Wold, W. S. M., Chambers, T. J. (2008). Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model. J. Virol. 82: 12510-12519 [Abstract] [Full Text]  
  • Prestwood, T. R., Prigozhin, D. M., Sharar, K. L., Zellweger, R. M., Shresta, S. (2008). A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads. J. Virol. 82: 8411-8421 [Abstract] [Full Text]  
  • Lee, E., Lobigs, M. (2008). E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence. J. Virol. 82: 6024-6033 [Abstract] [Full Text]  
  • van Marle, G., Antony, J., Ostermann, H., Dunham, C., Hunt, T., Halliday, W., Maingat, F., Urbanowski, M. D., Hobman, T., Peeling, J., Power, C. (2007). West Nile Virus-Induced Neuroinflammation: Glial Infection and Capsid Protein-Mediated Neurovirulence. J. Virol. 81: 10933-10949 [Abstract] [Full Text]  
  • Clark, D. C., Lobigs, M., Lee, E., Howard, M. J., Clark, K., Blitvich, B. J., Hall, R. A. (2007). In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J. Gen. Virol. 88: 1175-1183 [Abstract] [Full Text]  
  • Palmer, D. R., Fernandez, S., Bisbing, J., Peachman, K. K., Rao, M., Barvir, D., Gunther, V., Burgess, T., Kohno, Y., Padmanabhan, R., Sun, W. (2007). Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells. J. Gen. Virol. 88: 148-156 [Abstract] [Full Text]  
  • Chambers, T. J., Jiang, X., Droll, D. A., Liang, Y., Wold, W. S. M., Nickells, J. (2006). Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.. J. Gen. Virol. 87: 3131-3140 [Abstract] [Full Text]  
  • Stiasny, K., Heinz, F. X. (2006). Flavivirus membrane fusion.. J. Gen. Virol. 87: 2755-2766 [Abstract] [Full Text]  
  • Lee, E., Wright, P. J., Davidson, A., Lobigs, M. (2006). Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination.. J. Gen. Virol. 87: 2791-2801 [Abstract] [Full Text]  
  • Misinzo, G., Delputte, P. L., Meerts, P., Lefebvre, D. J., Nauwynck, H. J. (2006). Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells.. J. Virol. 80: 3487-3494 [Abstract] [Full Text]  
  • May, F. J., Lobigs, M., Lee, E., Gendle, D. J., Mackenzie, J. S., Broom, A. K., Conlan, J. V., Hall, R. A. (2006). Biological, antigenic and phylogenetic characterization of the flavivirus Alfuy. J. Gen. Virol. 87: 329-337 [Abstract] [Full Text]  
  • Zhao, Z., Date, T., Li, Y., Kato, T., Miyamoto, M., Yasui, K., Wakita, T. (2005). Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J. Gen. Virol. 86: 2209-2220 [Abstract] [Full Text]  
  • Fry, E. E., Newman, J. W. I., Curry, S., Najjam, S., Jackson, T., Blakemore, W., Lea, S. M., Miller, L., Burman, A., King, A. M. Q., Stuart, D. I. (2005). Structure of Foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J. Gen. Virol. 86: 1909-1920 [Abstract] [Full Text]  
  • Mori, Y., Okabayashi, T., Yamashita, T., Zhao, Z., Wakita, T., Yasui, K., Hasebe, F., Tadano, M., Konishi, E., Moriishi, K., Matsuura, Y. (2005). Nuclear Localization of Japanese Encephalitis Virus Core Protein Enhances Viral Replication. J. Virol. 79: 3448-3458 [Abstract] [Full Text]  
  • Reddi, H. V., Kumar, A. S. M., Kung, A. Y., Kallio, P. D., Schlitt, B. P., Lipton, H. L. (2004). Heparan Sulfate-Independent Infection Attenuates High-Neurovirulence GDVII Virus-Induced Encephalitis. J. Virol. 78: 8909-8916 [Abstract] [Full Text]  
  • Lee, E., Hall, R. A., Lobigs, M. (2004). Common E Protein Determinants for Attenuation of Glycosaminoglycan-Binding Variants of Japanese Encephalitis and West Nile Viruses. J. Virol. 78: 8271-8280 [Abstract] [Full Text]  
  • Escribano-Romero, E., Jimenez-Clavero, M. A., Gomes, P., Garcia-Ranea, J. A., Ley, V. (2004). Heparan sulphate mediates swine vesicular disease virus attachment to the host cell. J. Gen. Virol. 85: 653-663 [Abstract] [Full Text]  
  • Nickells, M., Chambers, T. J. (2003). Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice. J. Virol. 77: 12232-12242 [Abstract] [Full Text]  
  • Zhang, Y., Rassa, J. C., deObaldia, M. E., Albritton, L. M., Ross, S. R. (2003). Identification of the Receptor Binding Domain of the Mouse Mammary Tumor Virus Envelope Protein. J. Virol. 77: 10468-10478 [Abstract] [Full Text]  
  • Lobigs, M., Mullbacher, A., Wang, Y., Pavy, M., Lee, E. (2003). Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J. Gen. Virol. 84: 567-572 [Abstract] [Full Text]  
  • Zhao, Q., Pacheco, J. M., Mason, P. W. (2003). Evaluation of Genetically Engineered Derivatives of a Chinese Strain of Foot-and-Mouth Disease Virus Reveals a Novel Cell-Binding Site Which Functions in Cell Culture and in Animals. J. Virol. 77: 3269-3280 [Abstract] [Full Text]  
  • McArthur, M. A., Suderman, M. T., Mutebi, J.-P., Xiao, S.-Y., Barrett, A. D. T. (2002). Molecular Characterization of a Hamster Viscerotropic Strain of Yellow Fever Virus. J. Virol. 77: 1462-1468 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»